RALLYBIO CORP (RLYB) Stock Income Statement
NASDAQ:RLYB - Nasdaq - US75120L1008 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 848.00K | 636.00K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 51.23M | 61.13M | 78.93M | 67.88M | 45.64M | |||
| Research and Development | 34.30M | 41.51M | 53.54M | 40.69M | 26.91M | |||
| Selling, General, and Administrative Expenses | 16.93M | 19.63M | 25.39M | 27.20M | 18.74M | |||
| Operating Income | -50.38M | -60.50M | -78.93M | -67.88M | -45.64M | |||
| Interest Income/Expense | 3.58M | 4.22M | 6.15M | 1.96M | 40.00K | |||
| Other Income/Expense | 751.00K | 744.00K | 262.00K | 340.00K | 100.00K | |||
| Non Recurring Items | -2.14M | -2.24M | -2.04M | -1.08M | -1.51M | |||
| Income Before Taxes | -48.19M | -57.77M | -74.56M | -66.65M | -47.01M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -48.19M | -57.77M | -74.56M | -66.65M | -47.01M | |||
| EBITDA | -50.26M | -60.37M | -78.78M | -67.71M | -45.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.08 | -1.33 | -1.84 | -2.09 | -1.84 | |||
| Non GAAP EPS | -1.09 | -1.35 | -1.84 | -2.11 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -5682.19% | -9084.12% | N/A | N/A | N/A | |||
| Operating Profit Margin | -5940.92% | -9511.95% | N/A | N/A | N/A | |||
All data in USD